XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.2

Restructuring charges, separation costs and impairment charges | 6 Months Ended
--- | ---
Jun. 29, 2025
Restructuring and Related Activities [Abstract] |
Restructuring charges, separation costs and impairment charges | Restructuring charges, separation costs and impairment charges We have ongoing restructuring initiatives consisting of the following: •a footprint realignment plan initiated in 2024 that includes the relocation of select manufacturing operations to existing lower-cost locations, the optimization of specific product portfolios through targeted rationalization efforts, the relocation of certain integral product development and manufacturing support functions, the optimization of certain supply chain activities and related workforce reductions (the "2024 Footprint realignment plan") and, •a footprint realignment plan initiated in 2023 that involves the relocation of certain manufacturing operations to existing lower cost locations, the outsourcing of certain manufacturing processes and related workforce reductions (the “2023 Footprint realignment plan”). The following tables provide a summary of our cost estimates and other information associated with these plans:
|  |  | 2024 Footprint Realignment plan |  | 2023 Footprint Realignment plan |  |
Plan expense estimates: |  |  | (Dollars in millions) |  |
Restructuring charges (1) |  |  | $16 million to $20 million |  | $4 million to $6 million |  |
Restructuring related charges (2) (3) |  |  | $21 million to $26 million |  | $7 million to $9 million |  |
Total restructuring and restructuring related charges |  |  | $37 million to $46 million |  | $11 million to $15 million |  |
Other plan estimates: |  |  |  |  |  |  |
Expected cash outlays |  |  | $31 million to $38 million |  | $11 million to $15 million |  |
Expected capital expenditures |  |  | $15 million to $17 million |  | $2 million to $3 million |  |
Other plan information: |  |  |  |  |  |  |
Period initiated |  |  | May 2024 |  | September 2023 |  |
Estimated period of substantial completion |  |  | End of 2025 |  | End of 2027 |  |
Aggregate restructuring charges |  |  | $13.5 million |  | $3.2 million |  |
Restructuring reserve: |  |  |  |  |  |  |
Balance as of June 29, 2025 |  |  | $10.3 million |  | $2.9 million |  |
Restructuring related charges incurred: |  |  |  |  |  |  |
Three months ended June 29, 2025 |  |  | $2.4 million |  | $0.9 million |  |
Six months ended June 29, 2025 |  |  | $6.2 million |  | $1.5 million |  |
Aggregate restructuring related charges |  |  | $12.8 million |  | $4.2 million |  |
(1)Substantially all of the charges consist of employee termination benefit costs. (2)2024 Footprint realignment plan restructuring related charges represent costs that are directly related to the program and consist primarily of project management costs and costs to relocate manufacturing operations and support functions to the new locations. Substantially all of the restructuring related charges are expected to be recognized within cost of goods sold. (3)2023 Footprint realignment plan restructuring related charges represent costs that are directly related to the program and principally constitute costs to transfer manufacturing operations to existing lower-cost locations and project management costs. Substantially all of these charges are expected to be recognized within cost of goods sold. 2024 Restructuring plan During the fourth quarter of 2024, we initiated the "2024 restructuring plan," which included initiatives to optimize operations, reduce costs and enhance efficiencies across our business lines, including the relocation of select office administrative operations. The plan is substantially complete and as a result, we expect future restructuring expenses associated with the plan to be immaterial. Restructuring charges, separation costs and impairment charges recognized for the three and six months ended June 29, 2025 and June 30, 2024 consisted of the following:
Three Months Ended June 29, 2025 |  |  |  |  |
| Termination Benefits |  | Other Costs (1) |  | Total
2024 Restructuring plan | $ | 40 |  |  | $ | 9 |  |  | $ | 49 |
2024 Footprint realignment plan | 1,101 |  |  | 55 |  |  | 1,156 |
2023 Footprint realignment plan | 87 |  |  | — |  |  | 87 |
Other restructuring programs (2) | (143) |  |  | 16 |  |  | (127) |
Restructuring charges | 1,085 |  |  | 80 |  |  | 1,165 |
Asset impairment charges | — |  |  | 8,117 |  |  | 8,117 |
Separation costs | — |  |  | 12,890 |  |  | 12,890 |
Restructuring charges, separation costs and impairment charges | $ | 1,085 |  |  | $ | 21,087 |  |  | $ | 22,172 |
Three Months Ended June 30, 2024 |  |  |  |  |
| Termination Benefits |  | Other Costs (1) |  | Total
2024 Footprint realignment plan | $ | 8,572 |  |  | $ | — |  |  | $ | 8,572 |
2023 Restructuring plan | (974) |  |  | 36 |  |  | (938) |
2023 Footprint realignment plan | 588 |  |  | 1 |  |  | 589 |
Other restructuring programs (3) | (373) |  |  | 5 |  |  | (368) |
Restructuring charges | $ | 7,813 |  |  | $ | 42 |  |  | $ | 7,855 |
Six Months Ended June 29, 2025 |  |  |  |  |
| Termination Benefits |  | Other Costs (1) |  | Total
2024 Restructuring plan | $ | 161 |  |  | $ | 60 |  |  | $ | 221 |
2024 Footprint realignment plan | 2,166 |  |  | 92 |  |  | 2,258 |
2023 Footprint realignment plan | 330 |  |  | 2 |  |  | 332 |
Other restructuring programs (2) | (143) |  |  | 25 |  |  | (118) |
Restructuring charges | 2,514 |  |  | 179 |  |  | 2,693 |
Asset impairment charges | — |  |  | 8,117 |  |  | 8,117 |
Separation costs | — |  |  | 16,117 |  |  | 16,117 |
Restructuring charges, separation costs and impairment charges | $ | 2,514 |  |  | $ | 24,413 |  |  | $ | 26,927 |
Six Months Ended June 30, 2024 |  |  |  |  |
| Termination Benefits |  | Other Costs (1) |  | Total
2024 Footprint realignment plan | $ | 8,572 |  |  | $ | — |  |  | $ | 8,572 |
2023 Restructuring plan | (818) |  |  | 82 |  |  | (736) |
2023 Footprint realignment plan | 743 |  |  | 3 |  |  | 746 |
Other restructuring programs (3) | (208) |  |  | 30 |  |  | (178) |
Restructuring charges | 8,289 |  |  | 115 |  |  | 8,404 |
Asset impairment charges | — |  |  | 2,110 |  |  | 2,110 |
Restructuring and impairment charges | $ | 8,289 |  |  | $ | 2,225 |  |  | $ | 10,514 |
(1) Other costs include facility closure, contract termination and other exit costs. (2) Includes activity primarily related to our 2023 Restructuring plan and our Respiratory divestiture plan. (3) Includes activity primarily related to our 2022 Restructuring plan, which has concluded. Impairment charges For the three and six months ended June 29, 2025 and the six months ended June 30, 2024, we recognized impairment charges of $8.1 million and $2.1 million, respectively, primarily related to our cessation of occupancy at certain leased facilities during those periods. Recently Announced Strategic Actions and Separation Costs On February 27, 2025, we announced our intention to create a new, independently traded public company comprising Acute Care (consisting of our Urology and Respiratory product categories, the majority of our Anesthesia product category and certain products within our Interventional Access and Surgical product categories), our Interventional Urology and OEM businesses (referred to collectively as "NewCo"). Our Vascular Access product category, most of our products within our Interventional Access and Surgical product categories and the VI Business will remain with Teleflex. Since announcing the intended separation, we have received a number of inbound expressions of interest in acquiring NewCo and, with oversight of the Board, we continue to actively explore the potential sale of NewCo in parallel with the potential spin transaction. The completion of any separation transaction and the achievement of tax-free status for U.S. tax purposes will be contingent upon various conditions and approvals, including approval of our Board of Directors, receipt of requisite regulatory clearances and compliance with applicable SEC requirements. There can be no guarantees that the proposed separation will be completed on the terms and within the timeframe we announced, or at all. During the three and six months ended June 29, 2025, we recognized separation costs of $12.9 million and $16.1 million, respectively, primarily consisting of consulting, legal, tax and other professional advisory services associated with the strategic actions.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration